Metacrine, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2018 | $65 M | No. 3 | $50 to $250 million | equity | SEC | |
| Nov 2017 | $22 M | No. 2 | $10 to $50 million | equity | SEC | |
| Jan 2015 | $38 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Metacrine, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2018).
SEC Form D · Jun 2018
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Jun 2018
That is all the official record says: Metacrine, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
14 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Alexandria Venture Investments, LLC | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| ARCH Venture Fund VIII, L.P. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| ARCH Venture Fund VIII Overage, L.P. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| ARCH Venture Partners VIII, LLC | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| ARCH Venture Partners VIII, L.P. | Venture capital | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Nea 16 GP, LLC | Other | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| NEA Partners 16, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| New Enterprise Associates 16, L.P. | Fund or asset manager | not stated | not stated | Held Series B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Polaris Entrepreneurs' Fund VII, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Polaris Management Co. VII, L.L.C. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| Polaris Partners VII, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| venBio Global Strategic Fund, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| venBio Global Strategic GP, L.P. | Fund or asset manager | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
| venBio Global Strategic GP, Ltd. | Company | not stated | not stated | Held Series A, B and C preferred stock, 10% owner (Form 3, 2020) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 26 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Kenneth Song | Executive officer | Jun 2018 |
| Patricia Millican | Executive officer | Jun 2018 |
| Ken Song | Executive officer | Dec 2017 |
| Trisha Millican | Executive officer | Nov 2016 |
| Neil McDonnell | Executive officer | Oct 2015 |
| Jackie Hernandez | Executive officer | Apr 2015 |
| Amir Nashat | Director | Jun 2018 |
| Carol Gallagher | Director | Jun 2018 |
| Kenneth Song | Director | Jun 2018 |
| Kristina Burow | Director | Jun 2018 |
| Richard Heyman | Director | Jun 2018 |
| Robert Adelman | Director | Jun 2018 |
| Ronald Evans | Director | Jun 2018 |
| Ken Song | Director | Dec 2017 |
| Neil McDonnell | Director | Oct 2015 |